Home » Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy
Biotech is one of the most regulated businesses on the planet, so it’s clear that if Aastrom Biosciences is going to get anywhere, it had better have a good strategy for working with U.S. drug regulators.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May